IDEAS home Printed from https://ideas.repec.org/r/eee/jhecon/v76y2021ics0167629620310432.html

Can policy affect initiation of addictive substance use? Evidence from opioid prescribing

Citations

Citations are extracted by the CitEc Project, subscribe to its RSS feed for this item.
as


Cited by:

  1. Mark Anderson, D. & Diris, Ron & Montizaan, Raymond & Rees, Daniel I., 2023. "The effects of becoming a physician on prescription drug use and mental health treatment," Journal of Health Economics, Elsevier, vol. 91(C).
  2. David Cho & Daniel I. García & Joshua Montes & Alison E. Weingarden, 2021. "Labor Market Effects of the Oxycodone-Heroin Epidemic," Finance and Economics Discussion Series 2021-025, Board of Governors of the Federal Reserve System (U.S.).
  3. Simone Balestra & Helge Liebert & Nicole Maestas & Tisamarie B. Sherry, 2021. "Behavioral Responses to Supply-Side Drug Policy During the Opioid Epidemic," NBER Working Papers 29596, National Bureau of Economic Research, Inc.
  4. Shishir Shakya & Jane E. Ruseski, 2023. "The effect of Prescription Drug Monitoring Programs on county‐level opioid prescribing practices and spillovers," Contemporary Economic Policy, Western Economic Association International, vol. 41(3), pages 435-454, July.
  5. Eichmeyer, Sarah & Zhang, Jonathan, 2023. "Primary care providers’ influence on opioid use and its adverse consequences," Journal of Public Economics, Elsevier, vol. 217(C).
  6. Evan D. Peet & David Powell & Rosalie Liccardo Pacula, 2024. "Using Policy and Innovation to Improve Life-Saving Access to Naloxone," NBER Working Papers 33105, National Bureau of Economic Research, Inc.
  7. Cecilia Diaz-Campo, Antonella Mancino, 2025. "What We RANDomly Did Not Learn: Wave Zero of the U.S. Opioid Epidemic," LCERPA Working Papers jc0156, Laurier Centre for Economic Research and Policy Analysis, revised Jun 2025.
  8. Aparna Soni, 2024. "Estimating price elasticities of demand for pain relief drugs: evidence from Medicare Part D," International Journal of Health Economics and Management, Springer, vol. 24(4), pages 481-515, December.
  9. David Cho & Alvaro Mezza & Joshua Montes, 2022. "Choices and Implications when Measuring the Local Supply of Prescription Opioids," Finance and Economics Discussion Series 2022-078, Board of Governors of the Federal Reserve System (U.S.).
  10. Johanna Catherine Maclean & Justine Mallatt & Christopher J. Ruhm & Kosali Simon, 2022. "The Opioid Crisis, Health, Healthcare, and Crime: A Review of Quasi-Experimental Economic Studies," The ANNALS of the American Academy of Political and Social Science, , vol. 703(1), pages 15-49, September.
  11. Donahoe, J. Travis & Drake, Coleman, 2025. "When do supply-side drug control policies save lives? Evidence from pharmacy methadone restrictions," Journal of Health Economics, Elsevier, vol. 104(C).
  12. William Encinosa & Didem Bernard & Thomas M. Selden, 2022. "Opioid and non-opioid analgesic prescribing before and after the CDC’s 2016 opioid guideline," International Journal of Health Economics and Management, Springer, vol. 22(1), pages 1-52, March.
  13. Alberto Ortega, 2023. "The highs and the lows: Recreational marijuana laws and mental health treatment," Health Economics, John Wiley & Sons, Ltd., vol. 32(10), pages 2173-2191, October.
  14. Burton, Anne M. & Churchill, Brandyn F., 2025. "Supply-side opioid restrictions and the retail pharmacy market," Journal of Health Economics, Elsevier, vol. 104(C).
  15. Denis Agniel & Jonathan H. Cantor & Johanna Catherine Maclean & Kosali I. Simon & Erin Taylor, 2023. "Insurance Coverage and Provision of Opioid Treatment: Evidence from Medicare," NBER Working Papers 31884, National Bureau of Economic Research, Inc.
  16. Broten, Nicholas & Dworsky, Michael & Powell, David, 2022. "Do temporary workers experience additional employment and earnings risk after workplace injuries?," Journal of Public Economics, Elsevier, vol. 209(C).
  17. Marius Opstrup Morthorst & David J. Price & Peter Rønø Thingholm, 2025. "The Effects of Layoffs on Opioid Use and Abuse," Working Papers tecipa-794, University of Toronto, Department of Economics.
  18. Thuy D. Nguyen & W. David Bradford & Kosali I. Simon, 2019. "How do Opioid Prescribing Restrictions Affect Pharmaceutical Promotion? Lessons from the Mandatory Access Prescription Drug Monitoring Programs," NBER Working Papers 26356, National Bureau of Economic Research, Inc.
  19. Gupta, Sumedha & Nguyen, Thuy & Freeman, Patricia R. & Simon, Kosali, 2023. "Competitive effects of federal and state opioid restrictions: Evidence from the controlled substance laws," Journal of Health Economics, Elsevier, vol. 91(C).
  20. Cotet-Grecu, Anca M. & Zanzalari, Danielle, 2026. "The impact of prescription drug monitoring programs on functional health," Economics & Human Biology, Elsevier, vol. 60(C).
  21. Matthew T. Knowles, 2022. "How access to addictive drugs affects the supply of substance abuse treatment: Evidence from Medicare Part D," Health Economics, John Wiley & Sons, Ltd., vol. 31(8), pages 1649-1675, August.
  22. Kim, Bokyung, 2021. "Must-access prescription drug monitoring programs and the opioid overdose epidemic: The unintended consequences," Journal of Health Economics, Elsevier, vol. 75(C).
  23. Andrei Barbos & Minglu Sun, 2025. "Opioid Control Policies Can Also Reduce Domestic Violence," Health Economics, John Wiley & Sons, Ltd., vol. 34(7), pages 1295-1308, July.
  24. Smart, Rosanna & Powell, David & Pacula, Rosalie Liccardo & Peet, Evan & Abouk, Rahi & Davis, Corey S., 2024. "Investigating the complexity of naloxone distribution: Which policies matter for pharmacies and potential recipients," Journal of Health Economics, Elsevier, vol. 97(C).
  25. Alice M. Ellyson & Jevay Grooms & Alberto Ortega, 2022. "Flipping the script: The effects of opioid prescription monitoring on specialty‐specific provider behavior," Health Economics, John Wiley & Sons, Ltd., vol. 31(2), pages 297-341, February.
  26. Mizushima, Yuji & Powell, David & Abouk, Rahi & Damberg, Cheryl, 2025. "Regulating quasi-legal markets: Evidence from pain management clinic laws," Journal of Public Economics, Elsevier, vol. 252(C).
  27. Shyam Raman & Johanna Catherine Maclean & W. David Bradford & Coleman Drake, 2023. "Recreational cannabis and opioid distribution," Health Economics, John Wiley & Sons, Ltd., vol. 32(4), pages 747-754, April.
  28. Bhashkar Mazumder, 2023. "The Effects of Prescription Drug Monitoring Programs on Labor Market Activity and Credit Outcomes," Working Paper Series WP 2023-13, Federal Reserve Bank of Chicago.
  29. Abouk, Rahi & Powell, David, 2021. "Can electronic prescribing mandates reduce opioid-related overdoses?," Economics & Human Biology, Elsevier, vol. 42(C).
IDEAS is a RePEc service. RePEc uses bibliographic data supplied by the respective publishers.